Literature DB >> 28050676

Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway.

Takashi Aoyama1, Osamu Imataki2, Keita Mori3, Kanako Yoshitsugu4, Masafumi Fukaya4, Ikue Okamura4, Terukazu Enami4, Raine Tatara4, Takashi Ikeda5.   

Abstract

Hematopoietic stem cell transplantation carries nutrition-related risks. Therefore, nutritional therapy needs to be initiated before transplantation even takes place. We assessed nutritional risk among patients who underwent allogeneic stem cell transplantation. We assessed nutrient supply (calorie supply and protein supply) by chart review. Assessments were made from the pretreatment phase of transplantation to after the end of parenteral nutrition in 51 patients who underwent allogeneic stem cell transplantation at Shizuoka Cancer Center between 2007 and 2012. We compared nutrition-related adverse events and parameters between two groups: those in whom % loss of body weight was ≥7.5 and those in whom % loss of body weight was <7.5. A correlation was observed between changes in weight and skeletal muscle mass (r = 0.89; P < 0.0001). A weak correlation was observed between % loss of body weight and nutrient supply of calories (r = 0.517; P = 0.0001). There were significant differences between the % loss of body weight ≥7.5 group and the % loss of body weight <7.5 group in the following variables: % loss of body weight, nutrient supply from calories and protein; orally ingested nutrient supply from calories and protein; start day of oral intake; and acute graft-versus-host disease. Orally ingested calories were negatively correlated with nutrition-related adverse events in both groups. Early and customized nutritional intervention may be optimal for all patients who undergo allogeneic stem cell transplantation to ameliorate body weight loss associated with nutrition-related adverse events.

Entities:  

Keywords:  Allogeneic blood stem cell transplantation; Bioelectrical impedance analysis; Nutrition-related adverse events; Nutritional pathway

Mesh:

Year:  2017        PMID: 28050676     DOI: 10.1007/s00277-016-2910-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.

Authors:  Mariana Henriques Ferreira; Leticia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques Lopes; Andrea Z Pereira; Nelson Hamerschlack; Luciana Corrêa
Journal:  Support Care Cancer       Date:  2019-06-24       Impact factor: 3.603

2.  Examining the Beneficial Aspects of Nutritional Guidance Using Estimated Daily Salt Intake in Cancer Patients with Ischemic Heart Disease.

Authors:  Takashi Aoyama; Takuya Oyakawa; Akifuimi Notsu; Emi Oiyama; Masao Hashimoto; Reiko Suzuki; Kei Iida
Journal:  Med Sci Monit Basic Res       Date:  2021-01-19

3.  The Metabolic Impact of Two Different Parenteral Nutrition Lipid Emulsions in Children after Hematopoietic Stem Cell Transplantation: A Lipidomics Investigation.

Authors:  Oscar Daniel Rangel-Huerta; María José de la Torre-Aguilar; María Dolores Mesa; Katherine Flores-Rojas; Juan Luis Pérez-Navero; María Auxiliadora Baena-Gómez; Angel Gil; Mercedes Gil-Campos
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

4.  Examination of a nutritional treatment pathway according to pretreatment health status and stress levels of patients undergoing hematopoietic stem cell transplantation.

Authors:  Takashi Aoyama; Osamu Imataki; Akifumi Notsu; Takashi Yurikusa; Koki Ichimaru; Masanori Tsuji; Kanako Yoshitsugu; Masafumi Fukaya; Terukazu Enami; Takashi Ikeda
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

5.  Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma.

Authors:  Takashi Aoyama; Osamu Imataki; Hidekazu Arai; Tetsuo Kume; Hitomi Shiozaki; Naomi Katsumata; Mariko Mori; Keiko Ishide; Takashi Ikeda
Journal:  Med Sci Monit Basic Res       Date:  2018-02-05

6.  Benefit of Reducing Body Weight Loss with A Nutritional Support Pathway in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Takashi Aoyama; Kanako Yoshitsugu; Masafumi Fukaya; Tetsuo Kume; Miho Kawashima; Kazuko Nakajima; Hidekazu Arai; Osamu Imataki; Terukazu Enami; Raine Tatara; Takashi Ikeda
Journal:  Med Sci Monit Basic Res       Date:  2019-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.